ZNF217: the Cerberus Who Fails to Guard the Gateway to Lethal Malignancy

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2021 Aug 6

PMID 34354851

Citations 6

Authors

Yingpu Li

Hao Wu

Qin Wang

Shouping Xu

Affiliations

Soon will be listed here.

Abstract

The aberrant expression of the zinc finger protein 217 (ZNF217) promotes multiple malignant phenotypes, such as replicative immortality, maintenance of proliferation, malignant heterogeneity, metastasis, and cell death resistance, via diverse mechanisms, including transcriptional activation, mRNA N-methyladenosine (mA) regulation, and protein interactions. The induction of these cellular processes by ZNF217 leads to therapeutic resistance and patients' poor outcomes. However, few ZNF217 related clinical applications or trials, have been reported. Moreover, looming observations about ZNF217 roles in mA regulation and cancer immune response triggered significant attention while lacking critical evidence. Thus, in this review, we revisit the literature about ZNF217 and emphasize its importance as a prognostic biomarker for early prevention and as a therapeutic target.

Citing Articles

Screening of necroptosis-related genes and evaluating the prognostic capacity, clinical value, and the effect of their copy number variations in acute myeloid leukemia.

Wen D, Yan R, Zhang L, Zhang H, Chen X, Zhou J BMC Cancer. 2025; 25(1):71.

PMID: 39806277 PMC: 11727709. DOI: 10.1186/s12885-025-13439-y.

ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers.

Wang Y, Ma C, Yang X, Gao J, Sun Z Cancer Manag Res. 2024; 16:49-62.

PMID: 38259608 PMC: 10802126. DOI: 10.2147/CMAR.S431135.

The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models.

Ye M, Liu T, Miao L, Zou S, Ji H, Zhang J Cancers (Basel). 2023; 15(23).

PMID: 38067329 PMC: 10705782. DOI: 10.3390/cancers15235625.

The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression.

Fahme P, Ramadan F, Le D, Nguyen Thi K, Ghayad S, Hussein N Cancers (Basel). 2022; 14(24).

PMID: 36551531 PMC: 9776013. DOI: 10.3390/cancers14246043.

New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer's Disease.

Hao Y, Xie B, Fu X, Xu R, Yang Y Biomolecules. 2022; 12(12).

PMID: 36551230 PMC: 9775548. DOI: 10.3390/biom12121802.

References

Bar-Shira A, Pinthus J, Rozovsky U, Goldstein M, Sellers W, Yaron Y . Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res. 2002; 62(23):6803-7. View

Thal D, Walter J, Saido T, Fandrich M . Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease. Acta Neuropathol. 2014; 129(2):167-82. DOI: 10.1007/s00401-014-1375-y. View

Shi Y, Sawada J, Sui G, Affar E, Whetstine J, Lan F . Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature. 2003; 422(6933):735-8. DOI: 10.1038/nature01550. View

Kuo K, Mao T, Chen X, Feng Y, Nakayama K, Wang Y . DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma. Clin Cancer Res. 2010; 16(7):1997-2008. PMC: 2848895. DOI: 10.1158/1078-0432.CCR-09-2105. View

Bellanger A, Donini C, Vendrell J, Lavaud J, Machuca-Gayet I, Ruel M . The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone. J Pathol. 2017; 242(1):73-89. DOI: 10.1002/path.4882. View

Pang B, Wang Q, Ning S, Wu J, Zhang X, Chen Y . Landscape of tumor suppressor long noncoding RNAs in breast cancer. J Exp Clin Cancer Res. 2019; 38(1):79. PMC: 6376750. DOI: 10.1186/s13046-019-1096-0. View

Hewitt S, Korach K . Estrogen Receptors: New Directions in the New Millennium. Endocr Rev. 2018; 39(5):664-675. PMC: 6173474. DOI: 10.1210/er.2018-00087. View

Turner J, Crossley M . The CtBP family: enigmatic and enzymatic transcriptional co-repressors. Bioessays. 2001; 23(8):683-90. DOI: 10.1002/bies.1097. View

Gao M, Guo G, Huang J, Kloeber J, Zhao F, Deng M . USP52 regulates DNA end resection and chemosensitivity through removing inhibitory ubiquitination from CtIP. Nat Commun. 2020; 11(1):5362. PMC: 7584643. DOI: 10.1038/s41467-020-19202-0. View

10.

Vilas C, Emery L, Denchi E, Miller K . Caught with One's Zinc Fingers in the Genome Integrity Cookie Jar. Trends Genet. 2018; 34(4):313-325. PMC: 5878116. DOI: 10.1016/j.tig.2017.12.011. View

11.

Hoffman K, Holmes F, Fraschini G, Esparza L, Frye D, Raber M . Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer. Cancer Chemother Pharmacol. 1996; 37(3):254-8. DOI: 10.1007/BF00688325. View

12.

Timmer M, Brankley S, Gorospe E, Sun G, Lutzke L, Iyer P . Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers. Gastrointest Endosc. 2014; 80(6):984-91. PMC: 4311726. DOI: 10.1016/j.gie.2014.06.023. View

13.

Kiavue N, Cabel L, Melaabi S, Bataillon G, Callens C, Lerebours F . ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics. Oncogene. 2019; 39(3):487-502. DOI: 10.1038/s41388-019-1001-5. View

14.

Costa-Pinheiro P, Montezuma D, Henrique R, Jeronimo C . Diagnostic and prognostic epigenetic biomarkers in cancer. Epigenomics. 2015; 7(6):1003-15. DOI: 10.2217/epi.15.56. View

15.

Zhang F, Liu S . Mechanistic insights of adipocyte metabolism in regulating breast cancer progression. Pharmacol Res. 2020; 155:104741. DOI: 10.1016/j.phrs.2020.104741. View

16.

Wang J, Zhou T, Wang T, Wang B . Suppression of lncRNA-ATB prevents amyloid-β-induced neurotoxicity in PC12 cells via regulating miR-200/ZNF217 axis. Biomed Pharmacother. 2018; 108:707-715. DOI: 10.1016/j.biopha.2018.08.155. View

17.

Peiro G, Diebold J, Lohrs U . CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. Am J Clin Pathol. 2002; 118(6):922-9. DOI: 10.1309/XYCB-UW8U-5541-U4QD. View

18.

Thillainadesan G, Chitilian J, Isovic M, Ablack J, Mymryk J, Tini M . TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell. 2012; 46(5):636-49. DOI: 10.1016/j.molcel.2012.03.027. View

19.

Weiss M, Snijders A, Kuipers E, Ylstra B, Pinkel D, Meuwissen S . Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol. 2003; 200(3):320-6. DOI: 10.1002/path.1359. View

20.

Zhai J, Li S, Cheng X, Chen Z, Li W, Du Y . A candidate pathogenic gene, zinc finger gene 217 (ZNF217), may contribute to polycystic ovary syndrome through prostaglandin E2. Acta Obstet Gynecol Scand. 2019; 99(1):119-126. DOI: 10.1111/aogs.13719. View